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Background: The present study aimed to analyze the association among depression, sleep quality, and quality of life using
the Japanese version of the Structured Clinical Interview for DSM-IV Axis I Disorders Non-Patient Edition (SCID-I/NP), and to
compare these findings with those obtained using self-reported scales, in an urban male working population in Japan.
Methods: The present study included 324 middle-aged participants (43.8 ± 8.37 years) (participation rate: 69.5%). The
Japanese version of the SCID-I/NP was administered by a single physician. Self-reported scales, including the Zung Self-
Rating Depression Scale (SDS), Epworth Sleepiness Scale (ESS), Pittsburgh Sleep Quality Assessment (PSQI), and 36-item
Short-Form Health Survey (SF-36) were used to assess depression, sleepiness, sleep quality, and quality of life, respectively.
Participants were then divided into a major depressive disorder (MDD) and control group based on the results of
structured interviews, following which self-reported scale scores were compared between the two groups.
Results: A total of 24 participants met criteria for MDD based on responses during structured interviews (current: 4; past:
20). Patients with MDD did not report feeling sleepier than those without psychiatric disorders (controls) (ESS: P = 0.184),
although they experienced slightly poorer sleep quality (PSQI: P = 0.052). In addition, participants of the MDD group
exhibited lower SF-36 subscale scores for general health (P = 0.002), vitality (P < 0.001), social functioning (P < 0.001), role
emotional (P = 0.004), and mental health (P < 0.001) domains, and higher SDS scores (P = 0.038) compared to controls.
The area under the receiver (AUC) operating characteristic curve for the detection of MDD was 0.631 and 0.706 for the
SDS and mental health subscales, respectively.
Conclusions: Our findings indicate that patients with MDD exhibit slightly poorer sleep quality and significantly poorer
quality of life compared to controls, and that the SF-36 may be used as an alternative to the SDS to screen for depression
in an urban male working population in Japan.
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Psychiatric disorders are highly prevalent and contrib-
ute substantially to the total burden on the general
population (Murray et al. 2010). In particular, the
Global Burden of disease report cites depressive disor-
ders as a leading cause of burden (Ferrari et al. 2013),
with more than 30,000 suicides committed in Japan
alone between 1998 and 2011 (Ministry of Health
et al. 2016). In 2005, the total cost due to depression
among adults in Japan was estimated to be 2 trillion
yen (164 trillion USD) (Sado et al. 2011). Thus,
adequate diagnosis remains a priority for mental
health researchers and professionals.
The Structured Clinical Interview for DSM-IV Axis I
Disorders (SCID-I) (First et al. 2002) is a semi-
structured instrument that allows for evaluation of the
most common mental health problems and has been
used as a reference in epidemiological studies (Kessler
et al. 2004; Pez et al. 2010). In Japan, the SCID-I has
been used to diagnose depression in pregnant patients
(Yoshida et al. 2001) and patients with cancer (Akechi
et al. 2004), and to verify psychiatric diagnoses in
case-control studies (Tsuchiya et al. 2005). However,
the SCID-I Non-Patient Edition (SCID-I/NP) (First
et al. 2002) requires a trained physician and is time-
consuming to administer, which may not be suitable
for screening in large populations. Thus, few Japanese
studies have utilized structured interviews in non-
clinical settings, instead relying on self-reported ques-
tionnaires for the assessment of psychiatric/affective
disorders. However, no studies to date have compared
self-reported scores and SCID-I/NP results in a non-
clinical Japanese population.
Suicidal ideation represents a severe symptom of
depression that disproportionately affects Japanese
men: Since 1998, 70.6 ± 0.01% of suicide victims in
Japan have been male (Ministry of Health et al. 2016).
Suicide attempts are not only a severe health problem,
but also contribute substantially to the economic
burden (Kadotani et al. 2014). Previous studies have
further indicated that the severity of depression is
associated with symptoms such as insomnia, daytime
sleepiness, short sleep duration, and a reduction in
productivity at work, even among undiagnosed
individuals (Jha et al. 2016; Penninx et al. 2008; Plante
et al. 2016; Baglioni et al. 2011; Nakada et al. 2015).
Therefore, in the present study, we aimed to analyze
the association among depression, sleep quality, and
quality of life using the Japanese version of the SCID-
I/NP (First et al. 2002), and to compare these findings
with those obtained using self-reported scales, in an
urban male working population in Japan in order to
determine the most effective instrument for screening
for depression.Methods
Participants
The present study included participants enrolled in an
ongoing sleep and health epidemiological study
(Nakayama-Ashida et al. 2008; Kadotani et al. 2011). A
cross-sectional survey was conducted in a group of 476
male employees at a wholesale company in Osaka, Japan,
from January 26, 2004, to December 19, 2005. Ten
participants were excluded because they changed their
workplace during the survey. Thus, 466 male employees
were invited to participate in our survey, and 396
answered the baseline questionnaire (85.0%). Of the total
number of respondents, 324 underwent face-to-face
SCID-I/NP interviews (participants), while 72 answered
the baseline questionnaire but did not participate in the
interview (non-participants). Sleep-wake cycle schedules
were obtained using 7-day sleep logs with coincident
wrist actigraphy (Actiwatch AW-Light: Mini-Mitter,
Bend, Ore.), which was recorded using one-minute bins
and analyzed by Actiware-Sleep ver. 3.4 (Mini-Mitter
Co. Inc., Bend, Ore.). The weekday sleep debt was calcu-
lated as the difference in sleep duration between week-
days and weekends as estimated via actigraphy.
Structured interviews
All interviews were performed by a single physician,
while another physician reviewed the results item by
item. The clinical editions of the SCID-I and SCID-I/NP
contain the same items, with the exception of those re-
lated to psychosis (First et al. 2002). Simple, brief items
are used to screen for psychosis in the SCID-I/NP (First
et al. 2002). Questions related to current or past depres-
sion were asked separately. Participants whose answers
were positive for at least one of the two screening ques-
tions for depression were asked further questions about
their specific depressive symptoms. Participants with
more than five out of nine symptoms or those currently
receiving treatment with antidepressants were classified
into a current major depressive disorder (MDD) group,
while those with past MDD diagnoses or who had been
previously treated with antidepressants were classified
into a past MDD group.
Questionnaires
The Zung Self-Rating Depression Scale (SDS) contains
20 items (Zung et al. 1965). Scores of ≤39, 40–49, and
≥50 on the Japanese SDS indicate no, mild, and
moderate-to-severe depressive symptoms, respectively
(Fukuda and Kobayashi 1983).
The Medical Outcomes Study 36-Item Short Form
Health Survey (SF-36) has been widely utilized to assess
health-related quality of life (QOL) (McHorney et al.
1993). The SF-36 contains 36 items across eight subscales:
physical functioning (PF), role limitations due to physical
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perceptions (general health: GH), vitality (VT), social
functioning (SF), role limitations due to emotional prob-
lems (role emotional: RE), and mental health (MH). For
each subscale, a score ranging from 0 (worst) to 100 (best)
is calculated and standardized to have a mean of 50 and a
standard deviation of 10.
The Epworth Sleepiness Scale (ESS) (Johns 1991) and
the Pittsburgh Sleep Quality Index (PSQI) (Buysse et al.
1989) were used to assess sleepiness and sleep quality,
respectively. Participants with ESS scores of >10 and
those with PSQI global scores of >5 were classified as
having sleepiness and sleep problems, respectively.
We used Japanese translations of the SCID-I/NP (First
et al. 2002), SDS (Fukuda and Kobayashi 1983), ESS
(Takegami et al. 2009), and PSQI (Doi et al. 2000), andFig. 1 Flow chart. Participants with both MDD and other psychiatric disord
MDD had been receiving treatment at the time of the study. MDD, major d
Axis I Disorders Non-Patient Editionthe Japanese version 2 of the SF-36 (Fukuhara et al.
1998).
Statistical analysis
Categorical data are presented as proportions, while con-
tinuous data are presented as means and standard devia-
tions. T-tests were used to compare differences in
continuous data between participants and non-participants.
Group proportions were compared using the chi-square
test. Receiver operating characteristic (ROC) curve analysis
was performed to compare the screening performance of
the questionnaires. Pairwise comparisons of ROC curves
were performed by calculating the standard error of the
area under the curve (AUC) and difference between the
two AUCs. Statistical analyses were performed using
MedCalc version 16.8.4 (MedCalc Software, Mariakerke,ers were classified into the MDD group. All participants with current
epressive disorders; SCID-I/NP, Structured Clinical Interview for DSM-IV
Table 2 Prevalence of psychiatric disorders
Disorder n (%)
Schizophrenia and other psychotic disorders 0 (0)
Affective disorders
Major depressive disorder (current) 4 (1.23)
Major depressive disorder (past) 20 (6.17)
Bipolar disorders 1 (0.31)
Other mood disorders 0 (0)
Anxiety disorders
Panic disorder 1 (0.31)
Generalized anxiety disorder 2 (0.62)
Specific phobia 7 (2.16)
Social phobia 2 (0.62)
Obsessive-compulsive disorder 1(0.31)
Other anxiety disorders 0 (0)
Eating disorders 0 (0)
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Results
A total of 85.0% (396/466) and 69.5% (324/466) of all
male employees at the company responded to the base-
line questionnaire and the SCID-I/NP, respectively
(Fig. 1). No statistical differences between the partici-
pants and non-participants were observed with respect
to age, body mass index, ESS, total sleep time (TST), or
SF-36 subscale scores (Table 1).
Four participants had current MDD, all of whom had
been receiving treatment at the time of the study.
Twenty participants had received past diagnoses of
MDD (Table 2). Six participants answered positively to
the screening question related to dysthymic disorder, al-
though they were diagnosed with different affective dis-
orders: Of the four participants with past depression,
one answered positively to the screening questions for
MDD but did not meet the diagnostic criteria for MDD,
and one was diagnosed with bipolar I disorder. None of
the participants were diagnosed with psychotic or eating
disorders. Thirteen participants were diagnosed with
anxiety disorders (panic disorder, 1; generalized anxiety
disorder, 2; specific phobia, 7; social phobia, 2;
obsessive–compulsive disorder, 1), three of whom had
received past diagnoses of MDD. Participants with
current or past MDD were combined into the MDDTable 1 Characteristics of study population
Variable Total eligible sample Participants Non-participants P-value
n 396 324 72
Age, years 44.2 ± 8.42 43.8 ± 8.37 45.7 ± 8.56 0.089
BMI, kg/
m2
23.6 ± 3.03 23.7 ± 3.07 23.2 ± 2.85 0.208
ESS 8.0 ± 4.3 8.1 ± 4.3 7.6 ± 4.4 0.305
PSQI 4.7 ± 2.0 4.8 ± 2.0 4.2 ± 1.9 0.011
TST, hour 5.9 ± 0.86 5.9 ± 0.85 6.0 ± 0.89 0.748
SF-36 PF 53.8 ± 6.28 53.8 ± 6.41 54.0 ± 5.69 0.746
RP 52.1 ± 7.80 52.3 ± 7.30 51.2 ± 9.71 0.332
BP 51.4 ± 9.63 51.4 ± 7.27 51.5 ± 11.2 0.893
GH 51.2 ± 8.88 51.0 ± 9.05 52.1 ± 8.07 0.341
VT 50.5 ± 8.54 50.2 ± 8.24 52.0 ± 9.71 0.110
SF 52.7 ± 8.00 52.8 ± 7.78 52.3 ± 8.97 0.620
RE 51.7 ± 7.90 51.5 ± 7.76 52.1 ± 8.54 0.567
MH 50.6 ± 8.90 50.6 ± 8.76 51.0 ± 9.57 0.715
Independent t-tests were performed to compare continuous data between
participants and non-participants. The total sleep time (TST) was obtained from
the questionnaire
PSQI Pittsburgh Sleep Quality Index, ESS Epworth sleepiness scale; Medical
Outcomes Study 36-item Health Survey (SF-36), PF physical functioning, RP role
limitations due to physical health (role-physical); BP, bodily pain, GH general
health perceptions, VT vitality, SF social functioning, RE role limitations due to
emotional problems (role-emotional); and MH mental healthgroup (n = 24), while those without psychiatric disorders
were classified into the control group (n = 290) (Fig. 1).
Participants of the MDD group exhibited a slight
impairment in sleep quality (Table 3). PSQI scores and
rates of poor sleep quality (PSQI > 5) were higher in the
MDD group, relative to those of controls. Sleepiness
(ESS) and sleep time parameters (TST, weekday sleep
debt, and SL) did not significantly differ between the
MDD and control groups.
Depressive symptoms and mental health-related QOL
were significantly impaired in the MDD group (Table 3).
Overall SDS scores and SDS depression category scores
were significantly worse in the MDD group. The GH,
VT, SF, RE, and MH subscale scores of the SF-36 were
significantly lower in the MDD group (Table 3).
ROC analyses revealed that the MDD group exhibited
significantly poorer scores than controls on the SDS and
five subscales of the SF-36 (Fig. 2) (Additional file 1:
Table S1). The AUC was highest for the MH subscale.
The diagnostic ability for depression was fair for the MH
[AUC: 0.712 (95% confidence interval (CI): 0.658–0.761),
P = 0.0001] and poor for the SDS [AUC: 0.631 (95% CI:
0.574–0.686), P = 0.0319] scales. No significant differ-
ence in AUC values was observed between SDS and SF-
36 subscale scores (SDS vs. GH: P = 0.3465, SDS vs. VT: P
= 0.3103, SDS vs. SF: P = 0.8470, SDS vs. RE: P = 0.3036,
SDS vs. MH: P = 0.0975).
Discussion
In the present study, we conducted SCID-I/NP inter-
views in an urban male working population in Japan
(n = 324). Participants with MDD exhibited impaired
sleep quality and mental health-related QOL, although
no significant differences in sleepiness or sleep duration
Table 3 Sleep, depression, and quality of life in participants
with major depressive disorders (MDD) and controls
MDD Control p-value
n 24 290
Age (years) 41.3 ± 6.98 44.2 ± 8.41 0.109
BMI (kg/m2) 23.1 ± 2.94 23.7 ± 3.03 0.344
PSQI 5.58 ± 2.28 4.76. ± 1.97 0.052
>5 (n, %) 12, 50.0% 84, 29.5% 0.037
ESS 9.26 ± 4.65 8.06 ± 4.19 0.184
>10 (n, %) 9, 37.5% 75, 26.7% 0.256
TST (questionnaire) (hr) 5.93 ± 0.57 5.90 ± 0.87 0.882
TST (actigraphy) (hr) 5.15 ± 0.87 5.22 ± 0.80 0.690
Weekday sleep
debt (Actigraphy)
(hr) 1.06 ± 1.78 0.80 ± 1.36 0.401
SL (actigraphy) (min) 15.3 ± 9.45 15.4 ± 16.4 0.970
SDS 38.8 ± 6.25 36.1 ± 6.26 0.038
≤39 12 200 0.020
40-49 11 70
≥50 1 5
SF-36 PF 53.4 ± 5.19 53.8 ± 6.57 0.746
RP 51.3 ± 6.89 52.5 ± 7.24 0.423
BP 48.5 ± 9.54 51.6 ± 9.23 0.107
GH 45.4 ± 9.27 51.4 ± 8.90 0.002
VT 44.6 ± 8.85 50.7 ± 7.90 <0.001
SF 46.7 ± 13.0 53.4 ± 6.64 <0.001
RE 47.4 ± 7.89 52.0 ± 7.44 0.004
MH 44.7 ± 8.50 51.3 ± 8.31 <0.001
Data were compared between participants without psychiatric disorders
(control) and those with current and past MDD using independent t-tests and
chi-square tests. Five, 9, 15, and four participants did not answer the PSQI, ESS,
SDS, and SF-36, respectively. Actigraphy data from 12 participants were
missing. Total sleep time (TST) was obtained from the questionnaires and via
actigraphy. Sleep latency (SL) and weekday sleep debt were estimated from
the actigraphy data. The weekday sleep debt was calculated as the TST on
weekends minus the TST on weekdays
PSQI Pittsburgh Sleep Quality Index, ESS Epworth sleepiness scale, Medical
Outcomes Study 36-item Health Survey (SF-36), PF physical functioning, RP role
limitations due to physical health (role-physical), BP bodily pain, GH general
health perceptions, VT vitality, SF social functioning, RE role limitations due to
emotional problems (role-emotional); and MH mental health
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trol groups. In our ROC analysis, the MH score had the
highest AUC among the GH, VT, SF, RE, MH, and SDS
scores, suggesting that MH may be a good alternative to
the SDS to screen for depression in a Japanese working
male population.
Previous studies have reported a strong association
among sleep problems, insomnia, and depression
(Ferrari et al. 2013). In accordance with these findings,
we observed impaired sleep quality in participants with
MDD. Surprisingly, however, we observed no association
among depression, sleepiness, and sleep duration param-
eters (TST, SL, weekday sleep debt) (Table 3). Althoughthis finding may have been due to our small sample size,
is it also possible that treatment parameters influenced
our results, as all participants with MDD were receiving
treatment at the time of the study.
In our ROC analysis, GH, VT, SF, RE, MH of SF-36 ex-
hibited slightly higher AUC and lower p-values than
SDS. Previous studies have reported that negatively
worded items in the SDS do not adequately screen for
depression in the Japanese population (Umegaki et al.
2016). However, the SF-36 also contains negatively
worded items, suggesting that factors other than nega-
tive wording are responsible for this difference. The SF-
36 utilizes norm-based scoring, in which the scale and
component summary scores have a mean of 50 and
standard deviation of 10 in the general population
(McHorney et al. 1993). This norm-based scoring system
may be beneficial for detecting changes in non-clinical
settings, in which most participants are likely to score
near the norm. Furthermore, we observed no significant
differences in AUCs between scores on the SDS and
these SF-36 subscales. Thus, these findings indicate that
the SF-36 can be used as an alternative to the SDS to
screen for depression.
The company setting of the present study may repre-
sent an ideal site for data collection, providing a suffi-
cient number of full-time, non-shift-working male
employees working in the same industry and with the
same employer, which allowed us to control for work en-
vironment factors such as occupational participation,
employment sector, and employment policies (Kadotani
et al. 2011).
Only a few psychiatric epidemiological studies have
been conducted in the general Japanese population.
Although some non-clinical studies have used the Com-
posite International Diagnostic Interview (CIDI) (Kawa-
kami et al. 2005), to our knowledge, previous Japanese
studies utilizing the SCID-I were performed in clinical
settings only. We used the SCID-I/NP in a Japanese
working population. Among the 324 total participants,
four (1.2%) and 20 (6.2%) had current and past diagnoses
of MDD, respectively, while 13 (4.0%) had anxiety disor-
ders. Furthermore, we observed no evidence of psychotic
or eating disorders among participants of the present
study, and that all patients with current MDD were
undergoing treatment at the time of the study. As re-
ported previously, the prevalence of affective and anxiety
disorders is lower in Japan than in Western countries
(Demyttenaere et al. 2004).
The present study possesses some limitations of note.
Our target population was not representative of the
Japanese population in general, but was specific to the
working male population in a Japanese urban area.
Furthermore, individuals with severe MDD or psychotic
disorders could not attend work and thus could not
Fig. 2 Receiver operator characteristic (ROC) curves for the detection of MDD. The area under the ROC curve (AUC) is presented with 95%
confidence intervals and p-values (Area = 0.5). SDS, Zung Self-Rating Depression Scale; Medical Outcomes Study 36-item Health Survey (SF-36)
subscales: GH, general health perceptions (general health); VT, vitality; SF, social functioning; RE, role limitations due to emotional problems (role
emotional); and MH, mental health
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lower prevalence of both disorders. Nevertheless, we had
a high participation rate of 69.5% (324/466). This survey
was a part of a sleep and health epidemiological study;
thus, participants with better sleep quality (lower PSQI
scores) may have been reluctant to participate. However,
TST was similar in participants and non-participants
(Table 1). Thus, our study sample did not appear to have
a self-selection bias, and our estimate of prevalence may
well represent that of the entire participant population
(i.e., all male employees of this company in the Osaka
prefecture) (Kadotani et al. 2011).
Conclusions
In the present study, participants with MDD exhibited
slightly poorer sleep quality and significantly poorer
QOL than those without. Our findings further indicate
that the SF-36, especially the MH subscale, may be used
as an alternative to the SDS for the screening of depres-
sion in the working Japanese male population.
Additional file
Additional file 1: Table S1. Diagnosis evaluations. (DOCX 25 kb)
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